Tissue Regenix, a regenerative medtech firm, signs deal with US partner to provide grafts for chronic wound suffers in America.
Leeds spin-out Tissue Regenix has signed a processing partnership with US tissue bank Community Tissue Service, marking a major step forward for the commercialisation strategy of the Yorkshire-based medtech firm. Founded in 2006, Tissue Regenix is commercialising a biological scaffolding technology which enhances healing in chronic wound conditions. 87% of patients treated with the firm’s…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
